Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2011-11-24 Interim / Quarterly Rep…
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for RaySearch Laboratories AB covering the period 1 January to 30 September 2011. It contains comprehensive financial statements, including income statements, balance sheet summaries, and detailed management commentary on business performance, market trends, and future outlook. It is not a mere announcement (RPA) as it provides substantive financial data and analysis for the specified period. 9M 2011
2011-11-24 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim Report' for the period January 1 to September 30, 2011. It contains comprehensive financial statements, including net sales, operating profit, cash flow, and earnings per share, along with detailed management commentary and analysis of business operations. It is not an announcement of a report, but the report itself, fitting the definition of an Interim/Quarterly Report (IR). 9M 2011
2011-11-24 English
RAYSEARCH ENTERS SOUTH KOREAN DISTRIBUTION AGREEMENT
Regulatory Filings Classification · 92% confidence The document is a press release dated November 21, 2011, announcing that RaySearch Laboratories AB has entered into an exclusive distribution agreement with a South Korean distributor (OTS) for its RayStation® treatment planning system. This announcement concerns a business development, specifically a new commercial partnership and market expansion into Asia. This type of announcement—a strategic business development or partnership agreement—does not fit neatly into the specific financial reporting categories (10-K, ER, IR, etc.) or shareholder communication categories (AGM-R, DEF 14A). It is a general corporate announcement. Given the available options, the most appropriate fallback category for a significant, non-standard regulatory or financial announcement is 'Regulatory Filings' (RNS), as it covers miscellaneous filings that do not fit elsewhere, although 'Capital/Financing Update' (CAP) might sometimes cover strategic deals, this is purely a distribution agreement, not fundraising or capital structure change. Therefore, RNS is the best fit as a general corporate/business update.
2011-11-21 English
RAYSEARCH INGÅR DISTRIBUTIONSAVTAL FÖR SYDKOREA
Regulatory Filings Classification · 91% confidence The document is a press release dated November 21, 2011, announcing that RaySearch Laboratories AB has entered into an exclusive distribution agreement with a South Korean distributor (OTS) for its RayStation® product. This announcement details a strategic business development, specifically a partnership agreement, which falls under general corporate or business updates. It is not a formal regulatory filing like a 10-K, an earnings release (ER), a capital change (CAP), or a director's dealing (DIRS). Since it is a specific business announcement that doesn't fit the highly specific categories like AGM-R, 10-K, ER, CT, or DIV, the most appropriate general category for significant, non-standard corporate news that isn't a mandatory regulatory filing is 'Regulatory Filings' (RNS) as a fallback for miscellaneous announcements, although 'TAR' (M&A Activity) is for mergers/takeovers, and this is a distribution agreement. Given the options, and since it's a press release announcing a significant business deal (distribution agreement), it is best classified as a general regulatory announcement or miscellaneous filing, which aligns best with RNS, as it is not a report itself but an announcement of a business event.
2011-11-21 Swedish
New York hospital selects RayStation® for advanced research
Regulatory Filings Classification · 98% confidence The document is titled "PRESS RELEASE" and announces a specific business event: a New York hospital selecting RayStation® treatment planning system from RaySearch Laboratories AB. It details the order, quotes involved parties, and provides background information on the product and the company. This structure—a formal announcement of a business development, contract, or event—does not fit the specific financial filing categories like 10-K, ER, or IR. It is a general corporate announcement regarding business operations and sales, which is best categorized as a general Regulatory Filing (RNS) or potentially a miscellaneous announcement, as it is not a standard SEC filing, earnings release, or management change notice. Given the options, RNS serves as the best general regulatory/corporate announcement fallback.
2011-10-21 English
Sjukhus i New York väljer RayStation® för avancerad forskning
Regulatory Filings Classification · 98% confidence The document is a press release dated October 21, 2011, announcing a new order for the RayStation® system from a New York hospital. It details the product features, the company's background (RaySearch Laboratories AB), and contact information. This type of announcement, focusing on a specific business event (a new contract/sale) rather than comprehensive financial results (ER, IR, 10-K) or management changes (MANG), fits best under a general regulatory announcement or news release category. Since there is no specific category for 'New Contract Announcement' and it is not a formal financial filing, the most appropriate fallback is 'Regulatory Filings' (RNS), which covers general regulatory announcements and miscellaneous filings.
2011-10-21 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.